bevacizumab · Medicine question

What blood disorder has been reported when bevacizumab is combined with sunitinib in patients with metastatic renal cell carcinoma?

Name: What blood disorder has been reported when bevacizumab is combined with sunitinib in patients with metastatic renal cell carcinoma?
Published: 2026-11-08T13:41:44.712Z

iatroX medicinesPublished 8 November 2026

The answer

Answer

Microangiopathic haemolytic anaemia (MAHA) was reported in patients with metastatic renal cell carcinoma receiving bevacizumab combined with sunitinib malate.

Sources for this answer

Avastin 25mg/ml concentrate for solution for infusionRoche Products Limited · emc · SmPC §4.5 Interaction with other medicinal products · Version 64Document updated 18 May 2026

Sources checked 8 November 2026

loading page…

Answer

Sources for this answer

Answer

Sources for this answer

More questions about bevacizumab